Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Jan 2019
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Adverse reactions
- Acronyms NISANIK
- Sponsors TETEC
- 04 Jan 2019 Planned End Date changed from 1 Sep 2019 to 1 Nov 2019.
- 04 Jan 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Nov 2019.
- 20 Dec 2017 New trial record